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Abbreviations 
 
GHSA:  Global Health Security Agenda 
 
IHR:     International Health Regulation 
 
COVID-19: Corona Virus Disease 2019 
 
SARS-CoV-2: Sever Acute Respiratory  
                    Syndrome by Coronavirus-2 
 
PCR: Polymerase Chain Reaction 
 
RT-PCR: Real Time Polymerase Chain 
                 Reaction 
 
NPI: Non-Pharmacological Intervention 
 
PI: Pharmacological Intervention 
 
CDC: Center for Disease Control and  
           Prevention 
 
WHO: World Health Organization 
 
WHA: World Health Assembly 
 
OIE: World Organization for Animal  
         Health 
BALF: Broncho-alveolar Lavage  
             Fluid 
 
IVD: In Vitro Diagnostic 
 
POC: Point of Care  
 
PON: Point of Need 
 
AI: Artificial Intelligence 
 
CRISPR: Clustered Regularly 
                  Interspaced Short  
                 Palindromic Repeats 
 
CT: Computed Tomography 
 
 
MRI: Magnetic Resonance Imaging 
 
 
FAO: Food and Agriculture  
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Background: Just eleven months after the first reported COVID-19 infection, the global 
tally has surpassed 60 million cases with a global death toll standing at 1.4 million. Even 
though with the launch of the Global Health Security Agenda in 2014, only 67 countries 
came under the umbrella of this agenda and trying to exchange as well as integrate various 
strengths to fight against massive threats of multiple infectious diseases. The current Covid-
19 pandemic basically exposed the paucity of capacities and capabilities of nations’ Bio-
surveillance System, even the so-called developed ones. 
Method: Cross-sectional study was carried out within the time period of the 16th 
September - 30th November 2020, taking into account the secondary data of COVID-19 
patients up to 22nd April 2020, in South Korea, Australia, & England as sample population. 
After the extensive analysis of the data-driven from the authorized websites of the three 
countries - the Incidence Rate (%) and Case Fatality Rate (%) according to age and sex 
groups were compared along with Crude Incidence Rate, Crude Mortality Rate, Age & 
Sex-Specific Incidence Rate, Age & Sex-Specific Mortality Rate, Age & Sex Adjusted 
Incidence rate, Age & Sex Adjusted Mortality rate, by plotting into charts and graphs.   
Results: In the case of all three countries, Incidence Rates are increasing with the increase 
in age of the population. Except for the female of South Korea, the incidence of COVID-
19 in both the other two countries were high in case of the male population. the mortality 
rate of male patients was higher than female patients in all age groups in all three countries. 
In the case of England, the Incidence Rate (%) and  Case Fatality Rate (%) according to 
age and sex groups along with Crude Incidence Rate, Crude Mortality Rate, Age & Sex-
Specific Incidence Rate, Age & Sex-Specific Mortality Rate, Age & Sex Adjusted 
Incidence rate, Age & Sex Adjusted Mortality Rate all are 30 to more than 100 times higher 
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than Australia and South Korea. Australia shows the lowest in COVID-19 infection and 
death rates among the countries in all aspects.   
Conclusion: This study shows the gaps of currently available bio-surveillance methods 
leading to an uncontrolled and unprecedented surge of the ongoing COVID-19 contagion 
and fatality world-wide, driving mankind into an uncertain future. Ameliorating the 
currently available bio-hazard and disease surveillance system by filling those gaps up 
along with the help of continuous need-based research and innovations, imply tremendous 
importance to overcome the current situation and to predict upcoming “Disease-X” threats. 
 
 







Since the starting of the current year, the world is facing the most overwhelming pandemic 
situation caused by SARS-CoV-2 infecting one tenth of the world population and killing 
more than one million people worldwide. Pandemic is a circumstance where planning is 
needed to be done preemptively to get rid of hundreds of thousands of mortalities and 
morbidities. Even though experts from all over the world were repeatedly warning about 
such unprecedented global pandemic of emerging diseases along with trying to capacitate 
the health security by a wide range of prevention, early detection, and response 
countermeasures, COVID-19 already proved how unprepared we were. From the very early 
of this pandemic we were in a deficit of strong and integrated enough bio-surveillance 
system. Lack of laboratory facility, personal protective equipment and critical care 
equipment facilitate this disease to rampage throughout the globe without any sign to be 
stopped. Now, while we are going through the 10th month of this COVID-19 pandemic, 
still there are lot of shortage of integrations in different aspects of prevailing surveillance 
system which turning all of our efforts in vein to halt the further spread of this contagion 
day by day. Still we have to focus on evaluation what we have made wrong and where we 
should indulge our best efforts to improve the system. In this thesis by comparing the 
current incidence rate and case fatality rate of COVID-19 cases according to different age 
and sex group of population and by focusing on the available bio-surveillance system of 
South Korea, Australia, and England, I intended to find out the required steps to be taken 
for more development in integrating of that in those three countries.              
 
 





Global Health Security Agenda 
The 58th World Health Assembly (WHA) concurred in May 2005 to reformulate the 
Regulations for International Health on the verge of increasing events of world-wide 
infectious diseases outbreaks, like- AIDS, SARS, MARS and a few intentional release of 
harmful pathogens (like Anthrax in USA) following Twin Tower Attack). It was updated 
in order to prevent, protect, monitor as well as provide a public health response to the 
international spread of communicable diseases, so that those become fully compatible in 
limiting public health threats, and to avoid undue conflict with international trade, traffic 
and economy. [1] 
The IHR (2005) issued additional responsibilities to WHO and the global health 
community to initiate and integrate the resources for capacity-building and emergency 
response. Although many countries have reinforced their IHR (2005) capabilities for 
disease detection and response, just around 20 percent have announced that they have 
completely fulfilled their requirements by the specified deadline of June 2012. [2]  
In this given context, during February 2014, the introduction of the Global Health 
Protection Agenda (GHSA) was launched to develop new approaches revitalizing capacity-
building for improved checking of emerging and re-emerging infectious diseases 
occurrences, whether natural, accidental or deliberate, endangering not only public health, 
but the interests of national, regional and global security. The three dimensions in which 
the GHSA goals are set taking in conjunction with their 11 action packages, prevention, 
detection and response, undeniably overlap with and strengthen the core capability criteria 
defined in the IHR agreement to identify, evaluate, report and respond.  
In the table below the “Prevent, Detect and Respond” mandate of Global Health Security 
Agenda the necessary recommendations to achieve the objectives: 
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Objectives and Recommendations under the “Prevent, Detect and Respond” mandate 
of GHSA   
 
Objectives under the 
“Prevention” mandate of GHSA 





Prevent the emergence and 
spread of antimicrobial drug-
resistant organisms 
 
Reduce factors that enable antimicrobial 
resistance (AMR); improve surveillance for 
AMR; promote appropriate and responsible use 
of antibiotics in all settings. 
 
Prevent the emergence and 
spread of emerging zoonotic 
disease 
 
Reduce factors that enable emergence of 
zoonotic disease threats; increase surveillance 
for novel zoonotic diseases; promote safe 





governing food safety 
 
 






Promote national biosafety 
and     biosecurity systems 
 
Develop multi-sectorial approaches to manage 
biological materials, including identifying, 
securing, monitoring, and storing dangerous 
pathogens in a minimum number of facilities; 
frameworks to advance safe and responsible 




Reduce the number and 
magnitude of infectious 
disease outbreak 
 
Establish effective programs for vaccination 
against epidemic-prone diseases and nosocomial 
infection control 
Objectives under the 
“Detection” mandate of GHSA 
Actions Recommended 




Launch, strengthen, and link                 
global networks for real-time 
bio-surveillance 
 
Establish monitoring systems that can predict 
and identify infectious disease threats 
 
Establish interoperable, networked information-
sharing platforms and bio-informatics systems 







Strengthen rapid and 
transparent     reporting in the 
event of health                        
emergencies of international 
concern 
 
Strengthen capabilities for accurate and 
transparent reporting to WHO, OIE, and FAO 
during emergencies 
 
Strengthen sample sharing 
in the event of health 
emergencies of international 
concern 
 
Rapid sample and reagent sharing between 




Develop and deploy novel 
diagnostics 
 
Strengthen country and regional 
diagnostic capacity at the point-of care and 
point-of-need 
 
Strengthen laboratory systems  
 
 
Strengthen laboratory systems capable of safely 
and accurately detecting dangerous pathogens 
with minimal bio-risk  
 
Train and deploy bio-





Build capacity through trained disease detectives 
and laboratory scientists 
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Objectives under the 
“Respond” mandate of GHSA 
Actions Recommended 




Develop an interconnected 
global network of emergency 
operations centers 
 
Establish emergency operations centers.  
 
Develop multi-sectorial 
response to biological 
incidents 
 
Establish trained, functioning, 
Multi-sectorial rapid response teams, 
with access to a real-time information system 
 
Develop capacity to attribute the 




Improve global access to 




Strengthen capacity to plan for, produce or 
procure, and deploy personal protective 
equipment, medications, vaccines, and technical 
expertise and to deploy nonmedical 
countermeasure 
 
GHSA encourages to build national capacities for early identification of biological hazard, 
characterization and transparent reporting. GHSA advocates for real-time "bio-
surveillance" to be launched, reinforced and linked by global networks, reinforcing the 
global standard for rapid and open reporting to international actors, rapid sample exchange, 
developing and deploying new diagnostics, strengthening laboratory systems, and training 
and deploying workforce of efficient and accurate bio-surveillance. [3] 
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     Section 1.2. 
Bio-surveillance 
Bio-surveillance is a complex concept characterized as active data collection, adequate 
analysis and interpretation of data from the biosphere that may be linked to the activity of 
diseases and threats to human or animal health, whether contagious, poisonous, metabolic 
or otherwise, irrespective of their deliberate or natural origin, with a view to early warning 
of health threats, health event detection and overall circumstantial awareness of disease 
activity.[4] It encompasses all attempts by public health authorities to collect and analyze 
information on hazards and risks of importance to public health, including disease 
outbreaks that occur naturally, reportable ailments and syndromes, zoonotic disease events, 
environmental exposures, natural disasters, and terrorism-related malady. [5] 
The four essential functions of  basic surveillance include [6] –  
1) Detecting and documenting cases of disease in particular populations;  
2) Reviewing and verifying the reported data with case information for the 
identification of outbreak  
3) prompt provision of  appropriate responses at local / regional level and to allow 
for reasonable national-level disease prevention and control from outbreaks. 
4) Epidemiological Knowledge along with epidemilogical intelligence to help 
with long-term public policy, regulation and services on health and health care. 
Health care surveillance refers to the continuous systematic compilation, review, 
interpretation and relaying of data.  
Passive surveillance which is the crucial element of global biosurveillance, is much more 
convenient as well as easy to incorporate and free of technical hurdles. It is preeminently 
used with other approaches to point out a treatment quickly and implement steps to 
safeguard public health, for instance prophylaxis, immunization, and quarantine. Even so, 
this sort of surveillance is also contingent on health care providers reporting actively as 
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well as the collection of data, which can result in substantial time gaps between the 
occurrence of an incident and the knowledge that there has been a public health problem, 
such as an outbreak of an infectious disease. These time-lags can mean that public health 
initiatives, such as steps to isolate people from society, can not be served successfully to 
reduce disease transmission. [5] Since it is presumably not prompt and precise enough to 
be used alone in tackling deliberate spread of bio-agents too. 
On the otherhand, much more effort, efficiencies and public health resources are obligatory 
for active surveillance to be effective. This surveillance includes outreach to particular 
organizations, such as sentinel health-care facilities or hospitals, to systematically collect 
disease information; thus it is usually conducted to look for a particular ailment like 
emergence, re-emergence or resurgence of a contagion. [4] 
However, if accurately planned and used, robust and real-time or near real-time bio-
surveillance methods, can reliably pinpoint the situations preceding the public health issue 
as it happens, enabling relevant authorities to safeguard and protect the population. In order 
to better comprehend the cause, mode of transmission, dose-response relationship, and 
other features of diseases or other health conditions, bio-surveillance systems can also 
provide potentially useful data for the study. Formulating a bio-surveillance systems with 
the potency to rapidly gather, evaluate and share diverse data types through key 
stakeholders is not beyond pragmatic, technical, political, ethical and legal issues. [5] 
A total integration of surveillance and alert system of any biological incident or accident 






For enhancing this vigilant system of disease-surveillance, a total combination of 
knowledge-based careful searching and sensing of upcoming diseases-events prior the 
occurrence of disease with concurrent bio-protective measures as well as national 
integration is indispensable. [9, 10, 11] Those capacities reflect the resources that a public 
health system needs to draw on: facilities, policies and practices, response systems, 
competent and skilled workers. These include legal, economic, and organizational 
dimensions as well as the intangible relationships between people and organizations that 
studies indicate are vital to efficient implication of crisis-plans and community resilience. 
Capacities are important but not sufficient to ensure optimum functioning of a technical 
Biosurveillance Data Space Novel data sources explored by BioAlirt [8] 
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process. Whereas capabilities for bio-surveillance identify the activities that a public health 
system is competent of taking to efficiently detect, categorize and respond appropriately to 
crisis situations: surveillance, epidemiological investigations, prevention and control of 
diseases, expanded capacity for health care, communication of threats to the public, and 
integration of dynamic response through an effectual incident management system. [12]  
Despite the huge rise in financial resources and expertise that our ability to improve 
biosurveillance has been propelled   throughout the last decade, there have been many 
problems that need to be tackled, all over the globe  When many systems are used 
combinely, the importance of disease monitoring systems to public health officials is 
highest.  Restricted integration and  miscommunication between the different private and 






















Coronavirus and COVID-19 
 
Being first discovered in 1965 by Tyrrell and Bynoe during research on human embryonic 
tracheal organ cultures obtained from the respiratory tract of an adult with a common cold, 
[13]  an extensive research on Coronavirus were performed till date.  These are single-
stranded, positive-sense RNA viruses and belong to the order Nidovireales, family 
Coronaviridae and subfamily Corovirinae. Coronavirus has the largest genomes among all 
RNA viruses that ranges from 26 to 32 kilobases in length, with G + C contents varying 
from 32% to 43%. These type of virus are predominantly associated with enteric and 
respiratory diseases in animals and humans. Subfamily coronavirinae further diverges into 
three major generas or groups-the alpha-Coronavirus (group 1), the beta-CoVs (group-2), 
and the gamma-CoV (group 3) characterized by varying genetic mkeup and antigenic 
cross-reactivity. Delta-CoVs, representing a novel genus of Coronaviruses were also later 
found in birds and pigs. Out of these, only alpha-CoV strains (HCoV-229E and HCoV-
NL63) along with beta-CoVs s (HCoV-HKU1, HCoV-OC43, severe acute respiratory 
syndrome coronavirus [SARS-CoV], and Middle East respiratory syndrome coronavirus 
[MERS-CoV]) have been identified as human pathogenic strains. Swine acute diarrhea 
syndrome (SARS-CoV), porcine transmissible gastroenteritis virus, and porcine enteric 
diarrhoea virus (PEDV) are a few examples of alpha alpha and beta-CoVs that hold the 
potential to pose heavy disease burden on livestock. [14] 
Currently, an ongoing pneumonia outbreak caused by a novel Coronavirus strain named 
SARSCoV2 belonging to the beta-coronavirus genera is an emerging threat to public health 
all over the world. Ongoing extensive research has suggested that bats are the natural 
reservoir and pangolins are probably the potential intermediate host of the virus, as 99% 





On January 8 2020, the pathogen of severe unexplained viral pneumonia was identified by 
sequencing as tentatively named the novel (new) coronavirus 2019 (2019-nCoV). On 
February 12, 2020, International Committee on Taxonomy of Viruses declared that 2019-
nCoV was officially named as SARS-CoV-2, and at the same day, World Health 
Organization declared the disease caused by SARS-CoV-2 was officially named as 
coronavirus disease 2019 (COVID-19). Till now, about 6 million of cases have been 
confirmed in 211 countries and territories such as the USA and Southeast Asia, including 
severe and death cases. 
An abundance of research is being conducted globally on this Novel Coronavirus strain to 
gain knowledge about its origin, evolutionary history, phylogeny, along with the 
transmission pattern with clinical symptoms and sequelae of this disease.  This thesis is an 
effort to affirm requirements for capacitating the bio-surveillance system for prevention of 



















COVID-19 Coronavirus Real Time PCR Kit 
Currently WHO authorized COVID-19 Coronavirus Real Time PCR Kit is an In Vitro 
Diagnostic (IVD) reagent that relies on fluorescent PCR technology with the aim to 
qualitatively detect SARS-CoV-2 from both upper and lower respiratory tract-specimens. 
Specimens collected from upper respiratory tract include throat swab and nasopharyngeal 
swab and those from lower respiratory tract include sputum. Sampling objectives focus on 
suspected cases infected by SARS-CoV-2, suspected cases due to overcrowding, other 
cases needed to be diagnosed with SARS-CoV-2, and other suspected environmental and 
biomaterials (for traceability analysis, for example). Sampling should be carried out by 
well trained professionals with biosafety and experimental skills. Typically, SARS-CoV-2 
RNA could be detected from upper and lower respiratory tract specimens if a person is 
infected. Positive result suggests SARS-CoV-2 infection but bacteria and other virus 
induced co-infection could not be excluded. SARS-CoV-2 test result is not the only 
confirmation evidence of suspected cases and all positive results have to be reported to 
Centers for Disease Control (CDCs) and authorities. However negative result cannot 
straightforwardly exclude SARS-CoV-2 infection as well as the only decision-making 
evidence for treatment and patient management. Since negative result should be correlated 
with medical history, clinical observation and epidemiological information. The test is only 
available to equipped and certificated clinical laboratories and PCR laboratories and the 
technicians carrying out SARS-CoV-2 nucleic acid testing should be well trained with 
laboratory biosafety and PCR experimental skills. [15] 
As broncho-alveolar lavage fluid (BALF) samples are not practical for the routine 
laboratory diagnosis and monitoring of the disease, collection of other samples such as 
sputum, nasal swab, and throat swab is rapid, simple, and safe; even though, detection of 
viral RNAs in BALF is much dependable for the diagnosis and monitoring of viruses in 
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severe cases, since gathering of BALF needs both a suction tool and an expert operator, in 
addition to being painful to the patients. 
An important issue with the real-time RT-PCR test is the risk of eliciting false-negative and 
false-positive results. It is reported that many ‘suspected’ cases with typical clinical 
characteristics of COVID-19 and identical specific computed tomography (CT) images 
were not diagnosed. [16] Thus, a negative result does not exclude the possibility of 
COVID19 infection and should not be used as the only criterion for treatment or patient 
management decisions. It seems that combination of real-time RT-PCR and clinical 
features facilitates management of SARS-CoV-2 outbreak. Several factors have been 

































Study Design: Cross-Sectional Study 
Study Period: 16th September - 30th November 2020 
Sample Population: COVID-19 patients in South Korea, Australia, & England. 
Sample Size: Total COVID-19 patients in South Korea, Australia, & England extracted 
from the database of bellow sources. 
Data Collection Tool: Data collection sheet 
Data Management & Analysis Plan: Data will be checked and edited after collection. 
 Chart by spreadsheet of window 7. 
 Cross tabulation will be prepared and a comparison will be made between the data 
driven about three countries from above sources. 
 Graphical representation and interpretation of data. 
Quality Control and Quality Assurance: All effort will be made to reduce the likelihood 
of important errors which compromise the essential integrity of the research data. Data will 
be collected by principal investigator as a result there will be minimum bias on the research 
and PI will also monitor all the steps in the study. 
Expected Outcome / Impact: 
1) People of certain age-groups in given countries are more vulnerable to get 
COVID-19 infection. 
2) People of certain age-groups in given countries have higher death rate due to 
COVID-19 infection 
3) Male sex are more vulnerable than Female sex to be infected and dead in 
COVID-19. 





Types of Data: Secondary 
Source of Data: Secondary data of COVID-19 patients in South Korea, Australia, & 
England (UK). 
Total COVID-19 patients in South Korea, Australia, England (UK) extracted from the 
database of following sources: 
1) Coronavirus Infection-19 Outbreak Status in Korea (Domestic Occurrence 
Status) Update: 22 April 14:08  page: 31   
https://www.cdc.go.kr/board/board.es?mid=a30402000000&bid=0030 
2) Coronavirus (COVID-19) current situation and case numbers, Department of 
Health, Australian Government 
https://www.health.gov.au/sites/default/files/documents/2020/04/coronavirus-
covid-19-at-a-glance-22-april-2020.pdf 
3) Weekly Coronavirus Disease 2019 (COVID-19) Surveillance Report, Summary 




Total population by Age and Sex in South Korea, Australia, England (UK) extracted from 
the database of following sources: 
4) https://worldpopulationreview.com/countries/south-korea-population 
5) https://worldpopulationreview.com/countries/australia-population 
6) https://worldpopulationreview.com/countries/united-kingdom-population  
 
 





Calculation of Incidence rate and Case fatality ratio (CFR) 
Incidence rate of COVID-19  
COVID-19 Incidence Rate in a specific Age & Sex group population (in 100,000 
population) 
     
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑡𝑜𝑡𝑎𝑙 𝐶𝑂𝑉𝐼𝐷−19 +𝑣𝑒 𝑐𝑎𝑠𝑒𝑠
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑡𝑜𝑡𝑎𝑙 𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑡ℎ𝑎𝑡 𝑔𝑟𝑜𝑢𝑝 




Case fatality ratio (CFR) [18] 
 COVID-19 Case fatality ratio (CFR, in %) among specific Age & Sex group of Patient =  
                                                                               
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑑𝑒𝑎𝑡ℎ 𝑓𝑟𝑜𝑚 𝑑𝑖𝑠𝑒𝑎𝑠𝑒
    𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑜𝑛𝑓𝑖𝑟𝑚𝑒𝑑 𝑐𝑎𝑠𝑒𝑠 𝑜𝑓 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐 𝑔𝑟𝑜𝑢𝑝











1. Incidence rates of COVID-19 Infection in South Korea, Australia, and England 
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            As we see from the table: 1  
In South Korea male patients of age group 0-9, 10-19 and 20-29 years are found 
more infected than their female counterparts while the female patients of after 30 




























29 years and females of 50-59 years got COVID-19 infection higher than the other 
age and sex group of people. 
On the other hand, Australia saw higher cases of confirmed contagion in males of 
30-39, 40-49, 60-69, 70-79, 80+ age group of people than women of those 
categories. Similar to South Korea Australia has higher cases in higher age groups 
of both genders except the age group of 20-29 years of population. 
Aside from above two countries, England experienced a sky rocketed cases in each 
age group of population and the infection among the higher age categories were 
soared in both sexes. Incidence rate of COVID-19 infection in female were 
exorbitant than their male counterpart from the age group of 0-49 years; the 
opposite scenario is seen in the age groups from 50 years and onwards while the 


















2. Comparison between Male & Female Crude Incidence Rate / 100,000 in South 
Korea, Australia, and England 
 











As we see from the table: 2 
The Crude Incidence Rate of COVID-19 in Female is more than that of Male in 
South Korea which is opposite to that of both Australia and England. Yet The 
Crude Incidence rate of both sexes in South Korea is lower than that of Australia 
and England. Data of England shows, for both sexes CIR is more than ten times 


































3. Comparison between Male & Female Adjusted Incidence Rate (IR) / 100,000 
in South Korea, Australia, and England 
 











As we see from the table: 3 
The Sex Adjusted Incidence Rate of COVID-19 in Female is more than that of 
Male in South Korea which is opposite to that of both Australia and England. Yet 
Adjusted Incidence Rate of both sexes in South Korea is lower than that of 
Australia and England. Data of England shows, for Male, Sex Adjusted Incidence 
Rate is more than nine times and six times higher than that of South Korea and 
Australia respectively, while for female, that is >7 times and >6 higher than that of 

































4. Comparison among the Case Fatality Rate (CFR) of COVID-19 Infection in 














             As we see from the table: 4, 
While examining the data extracted to interpret the Case fatality rate (CFR) of 
those three countries, 0% CFR was found for both sexes of 0-19 years of patients 
for all countries except England as it saw 3% CFR in males of 10-19 age categories. 
The female patients of South Korea and Australia along with male patients of 
Australia also have 0% case fatality rate up to 59 years of age. At the same time 
males of South Korea and females of England of up to 49 years of age experienced 
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CFR of 0%. In all three countries male patients had higher mortality rate than 
female patients which increased significantly with the increase of age while 
England experienced the highest CFR in both age and sex categories of COVID-
19 patients. The patients of 80+ age group of both sexes had much higher case 
fatality rate than any other age group which ranges from 1%-41%, except the 
female patients of England for which CFR decreased in 2% from age group of 70-






















5. Comparison between Male & Female Crude Mortality Rate (MR) from 
COVID-19 Infection per 100,000 population in South Korea, Australia, and 
England 
 











As we see from the table: 5 
The Crude Mortality Rate of COVID-19 in Male is more than that of Female in all 
three countries. Yet the Crude Incidence rate of both sexes in Australia is lower 
than that of South Korea and England. Data collected from England shows, for 
male, CMR is more than 43 times higher than that of South Korea and more than 
sixty nine times higher than that of Australia. At the same time CMR for Female 































6. Comparison between Male & Female Adjusted Mortality Rate (AMR) from 
COVID-19 Infection per 100,000 population in South Korea, Australia, and 
England 
 










As we see from the table: 6 
The Adjusted Mortality Rate of COVID-19 in Male is more than that of Female in 
all three countries. Yet the Adjusted Mortality Rate of both sexes in Australia is 
the lowest of all. Data collected from England shows, for male, AMR is more than 
58 times higher than that of South Korea and more than 87 times higher than that 
of Australia. At the same time AMR for Female in England is >64 times and >104 




























1. Comparison of Incidence rate (%) of COVID-19 Confirmed Cases among South 
Korea, Australia and England according to age group and sex                       
 
       
Figure: 1 Comparison of Incidence rate (%) of COVID-19 Confirmed Cases  
among South Korea, Australia and England according to age group and sex 
Infection rate  
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From the Figure: 1 it is clear that the percentage of COVID-19 incidence is huge in the 
elderly population in England than those of South Korea and Australia. At the same time, 
it is obvious from the graph that in England people of all age and sex groups had a huge 
incidence rate of infection when compared to other two countries. In South Korea the male 
of 20-29 years are more prone to infection among the all other age and sex groups followed 
by female of 50-59 years and 20-29 years of age. Conversely, in Australia, Female of 20-
29 years had higher incidence rate than their Male counterparts; here this group was 



















2. Comparison of CFR (%) of COVID-19 Confirmed Cases among South Korea, 
Australia and England according to age group and sex  
 
 
Figure 2 Comparison of CFR (%) of COVID-19 Confirmed Cases among South 






From the Figure: 2 it is clear that the Case Fatality Ratio (%) of COVID-19 is huge in the 
elderly male population in all three countries amongst which England saw the most deaths. 
At the same time, it is obvious from the graph that in England people of all age and sex 


















3. Age & Sex Specific Incidence Rate (IR) of COVID-19 Infection per 100,000 
population in South Korea, Australia, and England in different Age and Sex group  
        
 
Figure: 3 Age & Sex Specific Incidence Rate (IR) of COVID-19 Infection per 100,000 































Age groups (year) of population 
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As we see in graph,  
in all three countries, Age & Sex Specific IR per 100,000 population, increase with the 
increase of ages in both sexes. However, in case of England, Age & Sex Specific IR of 
Male of more than 80 years of age-group, gets more than 30 times higher than that of both 
South Korea & Australia. On the other hand, Age & Sex Specific IR of Female of more 
than 80 years of age-group gets >28 times higher and >46 time higher than that of South 
Korea & Australia Respectively. In all other age & sex groups of population, England 
shows highest Age & Sex Specific IR per 100,000 population. And South Korea shows the 













4. Age & Sex Adjusted Incidence Rate (IR) of COVID-19 Infection per 100,000 
population in South Korea, Australia, and England in different Age and Sex group 
 
 
Figure: 4 Age & Sex Adjusted Incidence Rate (IR) of COVID-19 Infection per 100,000 































Age groups (year) of population 
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As we see in graph,  
in all three countries, Age & Sex Adjusted IR per 100,000 population, increases with the 
increase of ages in both sexes. However, in case of England, Age & Sex Adjusted IR of 
Male of more than 80 years of age-group, gets more than 49 times higher than that of South 
Korea & 40 times higher than that of Australia. On the other hand, Age & Sex Adjusted IR 
of Female of more than 80 years of age-group gets >45 times higher and >58 time higher 
than that of South Korea & Australia respectively. In all other age & sex groups of 
population, England shows highest Age & Sex Adjusted IR per 100,000 population. And 















5. Age & Sex Specific Mortality Rate (MR) of COVID-19 Infected cases per 100,000 
population in South Korea, Australia, and England in different Age and Sex group  
        
 
Figure: 5 Age & Sex Specific Mortality Rate (MR) of COVID-19 Infected cases per 
100,000 population in South Korea, Australia, and England in different Age and Sex 
group  

































As we see in graph,  
in all three countries, Age & Sex Specific MR per 100,000 population, increases with the 
increase of ages in both sexes. However, in case of England, Age & Sex Specific MR of 
Male of more than 80 years of age-group, gets more than 42 times higher than that of South 
Korea & 66 times higher than that of Australia. On the other hand, Age & Sex Specific MR 
of Female of more than 80 years of age-group gets >39 times higher and >90 time higher 
than that of  South Korea & Australia respectively. In all other age & sex groups of 
















6. Age & Sex Adjusted Mortality Rate of COVID-19 Infected cases per 100,000 
population in South Korea, Australia, and England in different Age and Sex group  
              
 
Figure: 6 Age & Sex Adjusted Mortality Rate of COVID-19 Infected cases per 100,000 
population in South Korea, Australia, and England in different Age and Sex group  

































As we see in graph,  
in all three countries, Age & Sex Adjusted Mortality Rate per 100,000 population, increases 
with the increase of ages in both sexes. However, in case of England, Age & Sex Adjusted 
Mortality Rate of Male of more than 80 years of age-group, gets more than 67 times higher 
than that of both South Korea & 83 times higher than that of Australia. On the other hand, 
Age & Sex Adjusted Mortality Rate of Female of more than 80 years of age-group gets 
>61 times higher and >116 times higher than that of both South Korea & Australia 
respectively. In all other age & sex groups of population, England shows highest Age & 


















The detection of probabilistic SARS-CoV-2 infection symptoms, separately or collectively, 
is important for the search for well-classified recommendations of screening and self-
isolation to stop transmission. 92 percent reported cases having at least one symptom of 
fever, cough and dyspnea in the large population-based study including HCW in the United 
States, and this symptom triad has been reported as the hallmark symptoms of COVID-19 
infection. [19, 20, 21, 22] While fever in this study was one of the most common symptoms 
of seropositive HCW, anosmia and ageusia were the most predictive symptoms of SARS-
CoV-2 infection. Of these, anosmia appears in COVID-19 as a main symptom. [23]  
In line with the recent major multinational population-based cohort study examining 
possible COVID-19 symptoms, the findings of the current study report a clear correlation 
between anosmia, ageusia and COVID-19. [24] In additament, a straightforward 
correlation was established between the combinations of symptoms of anosmia and/or 
ageusia, malaise and fever along with anosmia and/or ageusia, malaise and cough and 
seroprevalence, signifying that these symptoms should be included in the guidelines for 
regular screening. Similar to many other studies, during analysis of the secondary data from 
South Korea, Australia, and England, the incidence rate and the fatality rate both were 
found the least among the children below 10 years of age. In less than 10% cases pediatric 
population were identified as index case. [25] In addition to that, unlike most other 
respiratory viruses, children do not appear to be a major vector for transmission of SARS-
CoV-2, rather most pediatric cases reported in family clusters. Most children usually have 
milder or atypical presentations such as headache and nasal discharge, and anosmia and 
abdominal symptoms. Sometimes these symptoms might be de-emphasized due to 
underreporting since the infants and children of younger age may not be able to express 
them. [26] However, in some studies it is observed that in the gastrointestinal tract of 
infected children, SARS-CoV-2 may live for a longer period than in the respiratory system. 
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The recurrent shedding of SARS-CoV-2 into the stools of infected children suggests the 
capacity for fecal excretion to spread the virus. At all levels, major efforts should be made 
to prevent the spread of infection among children after resuming the elementary school. 
[27]  
For Australia and England, the exact number of total cases disaggregated by sex was not 
provided in anywhere of the websites of government. In addition to that, although every 
type of categorization and graphical representation poses separate importance for data 
analytic process, it is important to enhance the inclusiveness of data acquisition and data 
types. For genders, it would be useful to include a third alternative, outside the 
stereotypical, to address the inaccurate values. Sex-disaggregation in an inclusive manner 
as well as data harmonization is undeniably a prerequisite for strengthening the capacity of 
global surveillance system. [28] 
Among men, susceptibilities toward COVID-19 diseases and the corresponding mortality 
rates are higher in all countries which may be caused by influence of male endocrine system 
to their immune system. At the same time endocrine alteration enhances 
immunosenescence effects contributing postmenopausal women more vulnerable to the 
infection along with imposed severity. Regular monitoring and evaluation of these 
vulnerable population category through organized biochemical and endocrine 
investigations as well as restoring central well-classified database accordingly are needed 
to be emphasized on. [29]   
Both Care-givers to sick in family setting and health-care stuffs are appear to be 
overwhelmingly female, a factor that would have influenced to higher infection rates for 
females than males in South Korea and England, as well as made them a potential source 
of infection during their asymptomatic or pre-symptomatic stage of ailment. During the 
sub-clinically infected they themselves became potential source of infection to other 
comorbid patients both male and female and as due to endocrine related cause males are 
more vulnerable to non-communicable diseases their mortality rate becomes higher. [30] 
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In addition to that, most of the worshiping places are frequently visited by females of all 
ages and male of particularly higher ages exposing them to extremely transmissible 
COVID-19 disease. [31] To overcome the dreadful outcome from spreading of this 
infection, diagnosis in the earliest possible time is “the must” through the combination of 
proper contact tracing and rapid detection method.  
While compared to South Korea and Australia, in England, often ethnic minorities 
experience significantly excess hospital deaths. Compared with the white British majority 
so far, official non-hospital deaths can only account for a small part of the difference. Age 
and place obviously play a part, but they do not reveal the real tale, while seemingly depict 
substantial disparities between various minority communities. It is possible that underlying 
health conditions, workplace exposure and a number of other variables are significant, with 
some more important for specific groups: Bangladeshi males have high rates of underlying 
health problems, while black Africans and Indian males are especially vulnerable to the 
virus because of their prevalence in healthcare roles. As further study is done, the 
significance of every other element for each category might become easier to understand. 
[32] 
Data extracted and interpreted here all have used RT-PCR method to confirm the diagnosis 
of COVID-19 cases as it is considered as a gold standard according to the guidance of WHO 
due to its high sensitivity and specificity in detection of infectious agents. Advanced 
equipment for laboratories and highly qualified technicians are the prerequisite of RT-PCR 
test. Moreover, it requires long assay reaction time up to 2 hours or more. As a result this 
method, though gold standard, is not suitable for Point of Need (PON) and Point of Care 
(POC) for case detection following enabling rapid Non-Pharmacological Interventions 
(NPI)  to halt the transmission as well as rapid Pharmacological interventions (PI) to check 
complications in susceptible population group. So Korea has invented and is still carrying 
on research for further improvising Rapid Antigen Detection kits with more than 95% 
sensitivity and specificity. A framework for massive molecular genetic tests, capable of 
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performing 15,000 to 25,000 PCR tests, has already been developed in Korea, and accurate 
testing takes only about six hours, since KDCA took a decision not to implement Rapid 
Diagnostic Tests through antigen detection with current prevalence of COVID-19 at this 
time. [33] Similarly, in Australia, currently available guidance does not approve the use of 
rapid antigen tests in present situation with low prevalence of cases. [34] On the other hand, 
with a very high incidence and prevalence of cases in England, RDT became a crucial tool 
to help   monitor this virus and make life more natural. After carrying out mass testing by 
RDT using antigen detection technology in Liverpool, this virus can be identified faster 
than ever before, even in people who do not have symptoms. Via applying a nose and throat 
swab to a special test kit, these tests detect if the virus is present. These lightweight portable 
tests demonstrate a point-of-care outcome in 15-30 minutes, without the need to be tested 
in a laboratory, like a pregnancy test. They directly detect the virus without the RT-PCR or 
LAMP (loop mediated isothermal amplification) amplification steps. An objective review 
of one test (the SD Biosensor test) showed that it had a 99.3 percent clinical precision and 
a 76.6 percent clinical sensitivity. [35] 
For upgrading the rapidity of such diagnostic capacity innovative diagnostics technology 
with high sensitivity, specificity, and reliability like CRISPR (Clustered Regularly 
Interspaced Short Palindromic Repeats). [36]  
No routine antibody test is done in any of the country among South Korea, Australia, and 
UK that can provide sero-prevalence data for better understanding of the true extent of 
COVID-19 infection throughout the country. As a result the age and sex group of 
population who remain asymptomatic during their active infection period never be 
addressed in national surveillance system as they become negative in RT-PCR test after a 
certain period of time. It has been seen in several studies that frontline health care worker 
who are mostly female of middle aged, found sero-positive albeit 10%-50% of them remain 
asymptomatic or have very mild symptoms that are not sufficient for clinical   diagnosis. 
[37, 38]  
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In South Korea, tracing the source of infection from inbound travelers to the people from 
most remote areas, through quick and accurate epidemiological investigation including 
quarantine of contacts, central and local governments respond to Suspected and confirmed 
COVID-19 cases. Necessary information, including the location of confirmed cases, is 
obtained via an interview with reported cases for epidemiological investigation. Interviews 
with healthcare workers and family members can also be conducted if appropriate. More 
objective data (medical records, mobile GPS, CCTV video, credit card records, even 
tracking through programed wristband etc. can be obtained and checked in the event that 
the acquired information is inadequate. To attend healthcare education, monitor their 
symptoms, and remain in self-quarantine, the contacts found during the investigation are 
needed. In order to avoid any new infections, information on the whereabouts of suspected 
cases is posted to websites. [39] South Korea has been using this automated contact tracing 
to monitor the spread of COVID-19, mostly setting the public health safety beyond the 
personal privacy of individuals, continuous research for improvisation of such   technolog
ies to safe-guard confidentiality is being carried on, though. [40] 
Similarly, like the ‘TraceTogether” app of Singapore, Australia develop its own COVID 
Safe app, as a cornerstone to its national public health policy early in the crisis. What is 
particularly fascinating about these cases is the privacy problems posed by the apps, and 
how they are addressed in each country, as well as the ways in which both the states 
interweave own immediate future of societal concerns and health policy through such an 
app. [41] 
It is difficult to understand why it took the UK so long to adopt a well privacy maintaining 
contact tracing app even when Singapore has had efficient track and trace technology in 
place since March, especially when Singapore's technology was open-sourced and 
obtainable for use by app developers around the world. Contact-tracing applications are 
gradually being released across the four nations of the UK about half a year after they 
entered the Covid-19 lockdown during mid-March. [42] 
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The most common features throughout these apps are real-time maps and notifications of 
reported cases as well as their proximity, home isolation with quarantine monitoring and 
control systems, direct government reporting and self-reporting of symptoms, and COVID-
19 education. Some more advanced services include regular physiological status self-
physical assessment as well as virtual medical consultations. [43] Even though supporters 
believe that apps using centralized approach offers prompt and valuable information about 
the spread of infection to epidemiological investigators, these apps has much more privacy 
risks. On the other hand, apps that use a decentralized approach are more confidentiality-
friendly, since the information remains on the devices of users. [44] 
Artificial Intelligence (AI) can quickly analyze uncommon, irregular and alarming 
symptom; thus beneficial in the diagnosis of the infected cases with the assistance of 
various medical imaging technologies like Computed tomography (CT), Magnetic 
resonance imaging (MRI) scan of human body. Thus generate warning to the patients and 
the healthcare authorities. [45, 46] AI can help analyze the level of infection by this virus 
identifying the clusters and ‘hot spots’ and can successfully do the contact tracing of the 
individuals and also to monitor them. It can predict the future course of this disease and 
likely reappearance along with projection of cases and mortality by quickly analyzing 
various data available in its neural platform. Thus strengthening AI based bio-surveillance 
can impact future patient care and address more potential challenges which reduce the 
workload of the healthcare staffs providing better outcome not only in prevention but case 
detection along with treatment. [47, 48]   
Moreover, geo-climatic and cluster-distribution of the genetically and /or point mutated 
unique strains of COVID-19 virus have been identified during research on “disease-
severity” and “high-transmissibility” in the European countries. [49] Thus high morbidity 
and mortality of immune-compromised patients infected by COVID-19 might be explained 
by the correlation with the disastrous consequences of these newer mutations. [50] Higher 
transmission potential of any mutant strains creates huge burden for Health Care Facilities 
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resulting rapid surge in death rates. Since health care personnel and care-givers are more 
vulnerable during treating patients therefore, a huge rampage of the virus is going on in 
those countries. The most troublesome state is that, till date, six countries, namely 
Denmark, Spain, the Netherlands, Sweden, Italy and the United States of America have 
reported SARS-CoV-2 in farmed minks to OIE. This variant is inter-transmissible between 
human and minks leading minks a potential reservoir of this strain. Preliminary findings 
from recently identified mink-associated variant indicate that this particular variant in both 
minks and the human cases shows moderately decreased sensitivity to neutralizing 
antibodies which poses a threat towards the vaccination failure along with increased 
incidence of re-infection by SARSCov-2 leading to much more morbidity and fatality. In 
this regard extensive surveillance, sampling and sequencing of SARS-CoV-2, not only to 
find out the animal reservoirs in our surroundings but to find out the extension of the variant 
in human clusters are needed to be identified. Along with it, timely and regular updating 
and integration of this genetic sequencing data into global initiative on sharing all influenza 
data (GISAID) is inevitable for strengthening “Bio-surveillance capacity” both nationally 
and internationally. [51] 
  
                                                 










This study is aimed to exhibit the gaps of currently available bio-surveillance strategy that 
has led the whole world into an unending surge of the COVID-19 contagion and fatality, 
driving the entire mankind into an apparently unending misery. Ameliorating currently 
available bio-hazard and disease surveillance system by filling those voids up, along with 
the help of incessant need-based research and innovations, imply a tremendous importance 
to overcome the current situation; This effort, at the same time, will enable the nations to 
exchange own concerns through a robust integration system under the Global Health 
Security Agenda, to become much more efficient in dealing accordingly with any 








                                                    






LIMITATIONS OF THE STUDY 
WITH RECOMMENDATIONS 
Integrated bio-surveillance capability building not only requires laboratory improvisation 
and technical synchronization but also it requires ethical aspects to be considered, so that 
confidential information are not being leaked from the server or mishandled by third 
party. In this regard much more intensified research in related fields are still in dire need 
to be coordinated with a strict view to halt of current pandemic in near future.  
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